Benign Prostate Hyperplasia (BPH) Treatment Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028

Segmented By Drug Treatment (Alpha Blockers, 5-Alpha Reductase Inhibitors, and phosphodiesterase-5 inhibitors), By Surgical Treatment (Transurethral resection of the prostate (TURP), Prostatic Urethral Lift (PUL), Prostatectomy, Laser Surgery, Transurethral Microwave Technique (TUMT), Transurethral Needle Ablation of the Prostate (TUNA), and Others), By End User (Hospitals & Clinics, , Ambulatory Surgical Centers, and Others), By Region

Published	Pages	Publisher	Report code
Apr 2023	113	TechSci Research	ASDR-620301

Published: Apr 2023 - Pages : 113 - Publisher : TechSci Research - Report code : ASDR-620301

1. Boston Scientific Corporation
2. Coloplast Corporation
3. Teleflex Incorporated
4. Olympus Corporation
5. Glaxo Smith Kline PLC
6. Eli Lily
7. Abott Laboratories
8. Medifocus Inc.
9. Urologix
LLC
10. Pfizer Inc

Global Benign Prostate Hyperplasia (BPH) Market - 2022-2029

This report can be of interest as well:

Global Benign Prostate Hyperplasia (BPH) Market - 2022-2029

Published: October, 2022 | Report code: ASDR-614372